Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 6
2005 3
2006 8
2007 12
2008 13
2009 16
2010 20
2011 22
2012 30
2013 32
2014 28
2015 33
2016 33
2017 37
2018 24
2019 22
2020 5
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Results by year

Filters applied: . Clear all
Page 1
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R. Houssiau FA, et al. Among authors: galeazzi m. Arthritis Rheum. 2002 Aug;46(8):2121-31. doi: 10.1002/art.10461. Arthritis Rheum. 2002. PMID: 12209517 Free article. Clinical Trial.
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative.
Dick AD, Rosenbaum JT, Al-Dhibi HA, Belfort R Jr, Brézin AP, Chee SP, Davis JL, Ramanan AV, Sonoda KH, Carreño E, Nascimento H, Salah S, Salek S, Siak J, Steeples L; Fundamentals of Care for Uveitis International Consensus Group. Dick AD, et al. Ophthalmology. 2018 May;125(5):757-773. doi: 10.1016/j.ophtha.2017.11.017. Epub 2018 Jan 6. Ophthalmology. 2018. PMID: 29310963 Free article.
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M, Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de Groot PG, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Fernández-Nebro A, Haro M, Amoura Z, Miyara M, Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA; Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies). Cervera R, et al. Ann Rheum Dis. 2015 Jun;74(6):1011-8. doi: 10.1136/annrheumdis-2013-204838. Epub 2014 Jan 24. Ann Rheum Dis. 2015. PMID: 24464962 Free article.
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.
Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernández-Nebro A, Boffa MC, Hughes GR, Ingelmo M; Euro-Phospholipid Project Group. Cervera R, et al. Among authors: galeazzi m. Arthritis Rheum. 2002 Apr;46(4):1019-27. doi: 10.1002/art.10187. Arthritis Rheum. 2002. PMID: 11953980 Free article.
Synovial Leishmaniasis.
Guidelli GM, De Stefano R, Galeazzi M, Selvi E. Guidelli GM, et al. Among authors: galeazzi m. Arthritis Rheumatol. 2016 Apr;68(4):931. doi: 10.1002/art.39541. Arthritis Rheumatol. 2016. PMID: 26663894 No abstract available.
Antiphospholipid syndrome's genetic and epigenetic aspects.
Iuliano A, Galeazzi M, Sebastiani GD. Iuliano A, et al. Among authors: galeazzi m. Autoimmun Rev. 2019 Sep;18(9):102352. doi: 10.1016/j.autrev.2019.102352. Epub 2019 Jul 16. Autoimmun Rev. 2019. PMID: 31323355 Review.
Biosimilars vs originators: Are they the same?
Sarzi-Puttini P, Marotto D, Caporali R, Galeazzi M, Atzeni F, Hamar A, Soós B, Szekanecz Z. Sarzi-Puttini P, et al. Among authors: galeazzi m. Autoimmun Rev. 2019 Dec;18(12):102404. doi: 10.1016/j.autrev.2019.102404. Epub 2019 Oct 19. Autoimmun Rev. 2019. PMID: 31639517 Review.
Interleukin-1 Inhibition in Behçet's disease.
Vitale A, Rigante D, Lopalco G, Selmi C, Galeazzi M, Iannone F, Cantarini L. Vitale A, et al. Among authors: galeazzi m. Isr Med Assoc J. 2016 Mar-Apr;18(3-4):171-6. Isr Med Assoc J. 2016. PMID: 27228638 Free article. Review.
New therapeutic solutions for Behçet's syndrome.
Vitale A, Rigante D, Lopalco G, Emmi G, Bianco MT, Galeazzi M, Iannone F, Cantarini L. Vitale A, et al. Among authors: galeazzi m. Expert Opin Investig Drugs. 2016 Jul;25(7):827-40. doi: 10.1080/13543784.2016.1181751. Epub 2016 May 10. Expert Opin Investig Drugs. 2016. PMID: 27163156 Review.
280 results